Adenovirus Keratoconjunctivitis and Ophtalmology
ADV-OPH
Complications of Adenovirus Keratoconjunctivitis in Ophthalmologists and Orthoptists: Epidemiology and Risk Factor, a Retrospective Questionnaire Analysis
1 other identifier
observational
1,000
1 country
1
Brief Summary
Adenovirus conjunctivitis is an epidemic disease registered as a common occupational disease for ophthalmologists and orthoptists. It can leave corneal sequelae even several years after infection. The primary aim of the study is to investigate the prevalence of these sequelae in the at-risk population of ophthalmologists and orthoptist. Secondary aim are to describe administrative procedures (occupational disease declaration and sick leave),infections characteristics; and risk factors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 21, 2019
CompletedFirst Submitted
Initial submission to the registry
June 2, 2020
CompletedFirst Posted
Study publicly available on registry
June 4, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2022
CompletedJune 4, 2020
May 1, 2020
2.9 years
June 2, 2020
June 3, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
epidemiology characteristics
history of adenovirus keratoconjunctivitis; history of sequels
Day 1
general characteristics - Sex
general characteristics - Sex
Day 1
general characteristics - Age range
general characteristics - Age range
Day 1
general characteristics - Profession
general characteristics - Profession
Day 1
Secondary Outcomes (3)
administrative procedure declaration
Day 1
infection characteristics
Day 1
risk factor
Day 1
Eligibility Criteria
French Ophtalmologist or orthoptist
You may qualify if:
- Ophtalmologist or orthoptist (interns, graduates and retirees)
- French
You may not qualify if:
- \- Foreign practitionner
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University hospital, Clermont-Ferrand
Clermont-Ferrand, 63000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 2, 2020
First Posted
June 4, 2020
Study Start
October 21, 2019
Primary Completion
October 1, 2022
Study Completion
October 1, 2022
Last Updated
June 4, 2020
Record last verified: 2020-05